168 related articles for article (PubMed ID: 9588881)
1. Langerhans cells in Langerhans cell granulomatosis are not actively proliferating cells.
Brabencova E; Tazi A; Lorenzato M; Bonay M; Kambouchner M; Emile JF; Hance AJ; Soler P
Am J Pathol; 1998 May; 152(5):1143-9. PubMed ID: 9588881
[TBL] [Abstract][Full Text] [Related]
2. Pulmonary Langerhans cell granulomatosis.
Soler P; Tazi A; Hance AJ
Curr Opin Pulm Med; 1995 Sep; 1(5):406-16. PubMed ID: 9363103
[TBL] [Abstract][Full Text] [Related]
3. Expression of apoptosis-regulatory proteins in lesions of pulmonary Langerhans cell histiocytosis.
Marchal J; Kambouchner M; Tazi A; Valeyre D; Soler P
Histopathology; 2004 Jul; 45(1):20-8. PubMed ID: 15228440
[TBL] [Abstract][Full Text] [Related]
4. Expression of cellular adhesion molecules in Langerhans cell histiocytosis and normal Langerhans cells.
de Graaf JH; Tamminga RY; Kamps WA; Timens W
Am J Pathol; 1995 Oct; 147(4):1161-71. PubMed ID: 7573361
[TBL] [Abstract][Full Text] [Related]
5. Evidence that Langerhans cells in adult pulmonary Langerhans cell histiocytosis are mature dendritic cells: importance of the cytokine microenvironment.
Tazi A; Moreau J; Bergeron A; Dominique S; Hance AJ; Soler P
J Immunol; 1999 Sep; 163(6):3511-5. PubMed ID: 10477625
[TBL] [Abstract][Full Text] [Related]
6. Proliferation indices in spontaneous canine lung cancer: proliferating cell nuclear antigen (PCNA), Ki-67 (MIB1) and mitotic counts.
Griffey SM; Kraegel SA; Madewell BR
J Comp Pathol; 1999 May; 120(4):321-32. PubMed ID: 10208729
[TBL] [Abstract][Full Text] [Related]
7. Lesions resembling Langerhans cell histiocytosis in association with other lymphoproliferative disorders: a reactive or neoplastic phenomenon?
Christie LJ; Evans AT; Bray SE; Smith ME; Kernohan NM; Levison DA; Goodlad JR
Hum Pathol; 2006 Jan; 37(1):32-9. PubMed ID: 16360413
[TBL] [Abstract][Full Text] [Related]
8. [Langerhans cell histiocytosis of jaws: a clinical pathological and immunohistochemical study].
Gao Y; Liu X; Liu J
Zhonghua Kou Qiang Yi Xue Za Zhi; 1998 Jan; 33(1):15-7. PubMed ID: 11774668
[TBL] [Abstract][Full Text] [Related]
9. Langerhans' cell histiocytosis cells are activated Langerhans' cells.
Emile JF; Fraitag S; Leborgne M; de Prost Y; Brousse N
J Pathol; 1994 Oct; 174(2):71-6. PubMed ID: 7965409
[TBL] [Abstract][Full Text] [Related]
10. Association of cell cycle-related gene products and NF-kappaB with clinical parameters in Langerhans cell histiocytosis.
Amir G; Weintraub M
Pediatr Blood Cancer; 2008 Feb; 50(2):304-7. PubMed ID: 17455317
[TBL] [Abstract][Full Text] [Related]
11. [Significance of the expression of nucleolar argyrophilic proteins and antigen Ki-67 in the evaluation of cell proliferative activity and in the prediction of minimal (T1) lung cancer].
Raĭkhlin NT; Bukaeva IA; Smirnova EA; Gurevich LE; Delektorskaia VV; Polotskiĭ BE; Laktionov KK; Ardzinba Ms
Arkh Patol; 2008; 70(3):15-8. PubMed ID: 18727426
[TBL] [Abstract][Full Text] [Related]
12. Use of the JL1 epitope, which encompasses the nonglycosylation site of CD43, as a marker of immature/neoplastic Langerhans cells.
Park HJ; Jeon YK; Lee AH; Oh YH; Park SH; Jung KC
Am J Surg Pathol; 2012 Aug; 36(8):1150-7. PubMed ID: 22790855
[TBL] [Abstract][Full Text] [Related]
13. Histiocytosis X (Langerhans' cell histiocytosis). Prognostic role of histopathology.
Risdall RJ; Dehner LP; Duray P; Kobrinsky N; Robison L; Nesbit ME
Arch Pathol Lab Med; 1983 Feb; 107(2):59-63. PubMed ID: 6600606
[TBL] [Abstract][Full Text] [Related]
14. Ki-67 (MIB1), p53, and Lewis-X (LeuM1) as prognostic factors of recurrence in T1 and T2 laryngeal carcinoma.
Sittel C; Eckel HE; Damm M; von Pritzbuer E; Kvasnicka HM
Laryngoscope; 2000 Jun; 110(6):1012-7. PubMed ID: 10852523
[TBL] [Abstract][Full Text] [Related]
15. [Expression of apoptosis and proliferation related genes in carcinogenesis of lung squamous cell carcinoma in rats].
Wang J; Chen HL; Zhu RQ; Diao LM; Jang M; Yang F; Liu MQ
Ai Zheng; 2003 May; 22(5):471-6. PubMed ID: 12753705
[TBL] [Abstract][Full Text] [Related]
16. Intraluminal fibrosis and elastic fiber degradation lead to lung remodeling in pulmonary Langerhans cell granulomatosis (histiocytosis X).
Fukuda Y; Basset F; Soler P; Ferrans VJ; Masugi Y; Crystal RG
Am J Pathol; 1990 Aug; 137(2):415-24. PubMed ID: 2386203
[TBL] [Abstract][Full Text] [Related]
17. Oral Langerhans cell histiocytosis.
Bartnick A; Friedrich RE; Roeser K; Schmelzle R
J Craniomaxillofac Surg; 2002 Apr; 30(2):91-6. PubMed ID: 12069511
[TBL] [Abstract][Full Text] [Related]
18. Langerhans cell (eosinophilic) granulomatosis. A clinicopathologic study encompassing 50 years.
Lieberman PH; Jones CR; Steinman RM; Erlandson RA; Smith J; Gee T; Huvos A; Garin-Chesa P; Filippa DA; Urmacher C; Gangi MD; Sperber M
Am J Surg Pathol; 1996 May; 20(5):519-52. PubMed ID: 8619419
[TBL] [Abstract][Full Text] [Related]
19. Pulmonary Langerhans' cells in patients with fibrotic lung disorders.
Kawanami O; Basset F; Ferrans VJ; Soler P; Crystal RG
Lab Invest; 1981 Mar; 44(3):227-33. PubMed ID: 6970300
[TBL] [Abstract][Full Text] [Related]
20. Langerhans cells in Langerhans cell histiocytosis and peripheral adenocarcinomas of the lung.
Colasante A; Poletti V; Rosini S; Ferracini R; Musiani P
Am Rev Respir Dis; 1993 Sep; 148(3):752-9. PubMed ID: 7690210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
